期刊文献+

^131I治疗分化型甲状腺癌的不良反应 被引量:17

Adverse effects of 131I therapy for differentiated thyroid cancer
原文传递
导出
摘要 ^131I治疗DTC已有50余年历史,其可降低疾病的复发率及病死率,目前已成为DTC的主要治疗手段之一。然而大剂量^131I对身体有辐射损伤风险,越来越多的研究集中于^131I治疗后的近期和远期不良反应。尽管尚有许多问题存在争议,但随着临床循证医学证据的增加,人们关于^131I治疗后的不良反应认识逐渐清晰。笔者就目前^131I治疗DTC对患者各系统的不良影响进行综述。大剂量^131I治疗引起的严重不良反应十分罕见,但是对各系统仍存在不同程度损害。临床医师应掌握循证医学证据,采取积极措施使治疗后不良反应发生率及严重程度降到最低。 DTC is considered the most common endocrine neoplasm, and 131I therapy has been proven to be an important component in the management strategy. Currently, most research focuses on the adverse effects of radiation exposure to 131I therapy. Some results, based on large-scale and long-term inves- tigation, show new information. Although 131I therapies are usually well tolerated, clinicians involved in the management of DTC need to be aware of the potential toxicity of 131I and take all measures to reduce these effects to a minimum. The aim of this review is to present the adverse effects of 131I therapy for DTC.
出处 《中华核医学与分子影像杂志》 CSCD 北大核心 2012年第6期474-477,共4页 Chinese Journal of Nuclear Medicine and Molecular Imaging
基金 教育部科学技术研究重点项目(210269) 湖北省教育厅自然科学研究项目(B20101206)
关键词 甲状腺肿瘤 放射疗法 碘放射性同位素 副作用 Thyroid neoplasms Radiotherapy Iodine radioisotopes Adverse effects
  • 相关文献

参考文献39

  • 1Kloos RT, Duvuuri V, Jhiang SM, et al. Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma. J Clin Endocrinol Metab, 2002, 87 : 5817-5820. 被引量:1
  • 2Van Nostrand D, Neutze J, Atkins F. Side effects of "rational dose" ^131I therapy for metastatic well-differentiated thyroid carcinoma. J Nucl Med, 1986, 27: 1519-1527. 被引量:1
  • 3Van Nostrand D. The benefits and risks of ^131I therapy in patients with well-differentiated thyroid cancer. Thyroid, 2009, 19 : 1381- 1391. 被引量:1
  • 4Guven A, Salman S, Boztepe H, et al. Parathyroid changes after high dose radioactive iodine in patients with thyroid cancer. Ann Nucl Med, 2009, 23: 437-441. 被引量:1
  • 5Grewal RK, Larson SM, Pentlow CE, et al. Salivary gland side effects commonly develop several weeks after initial radioactive iodine ablation. J Nucl Med, 2009, 50: 1605-1610. 被引量:1
  • 6Jentzen W, Hobbs RF, Stahl A, et al. Pre-therapeutie ^124I PET(/CT) dosimetry confirms low average absorbed doses per administered ^131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer. Eur J Nucl Med Mol Imaging, 2010, 37 : 884-895. 被引量:1
  • 7Liu B, Kuang A, Huang R, et al. Influence of vitamin C on salivary absorbed dose of ^131I in thyroid cancer patients: a prospective, randomized, single-blind, controlled trial. J Nucl Med, 2010, 51: 618-623. 被引量:1
  • 8Raza H, Khan AU, Hameed A, et al. Quantitative evaluation of salivary gland dysfunction after radioiodine therapy using salivary gland scintigraphy. Nucl Med Commun, 2006, 27: 495-499. 被引量:1
  • 9Ish-Shalom S, Durleshter L, Segal E, et al. Sialochemical and oxidative analyses in radioactive ^131I-treated patients with thyroid carcinoma. Eur J Endocrinol, 2008, 158 : 677-681. 被引量:1
  • 10Rosario PW, Borges MA, Purisch S. Preparation with recombinant human thyroid-stimulating hormone for thyroid remnant ablation with ^131I is associated with lowered radiotoxicity. J Nucl Med, 2008, 49 : 1776-1782. 被引量:1

二级参考文献14

  • 1Luster M, Clarke SE, Dietlein M, et al. Guidelines for radioiodine therapy of differentiated thyroid cancer [ J ]. Eur J Nucl Med Mol Imaging, 2008, 35(10): 1941 -1959. 被引量:1
  • 2Chung JK, Lee YJ, Jeong JM, et al. Clinical significance of hepatic visualization on iodine-131 whole body scan in patients with thyroid carcinoma[J]. J Nucl Med, 1997, 38(8): 1191 -1195. 被引量:1
  • 3Maayan MI, Eisenberg J, Lopez EM, et al. Hepatic visualization after 131-I in patients with thyroid carcinoma[ J]. N Engl J Med, 1977, 295(22) : 1258 - 1259. 被引量:1
  • 4Zeissman HA, Bahar H, Fahey FH, et al. Hepatic visualization on iodine-131 whole body thyroid cancer scans [ J]. J Nucl Med, 1987, 28(9) : 1408 -1411. 被引量:1
  • 5Tatar FA, Morita E,ltuarte PH, et al. Association between residual thyroid carcinoma and diffuse hepatic uptake of I-131 following radioiodine ablation in postoperative total thyroidectomy patients [J]. World J Surg, 2001, 25(6) : 718 -722. 被引量:1
  • 6Blum M. Hepatic visualization after 131-I in patients with thyroid carcinoma[J]. N Engl J Med, 1977, 296(11) : 634. 被引量:1
  • 7Rosenbaum RC, Johnston GS, Valente WA. Frequency of hepatic visualization during 1-131 imaging for metastatic thyroid carcinoma [J]. Clin Nucl Med, 1988, 13(9): 657 -660. 被引量:1
  • 8Carlisle MR, Lu C, McDougall IR, The interpretation of 131-I scans in the evaluation of thyroid cancer, with an emphasis on false positive findings [ J]. Nucl Med Commun, 2003, 24 (6) : 715 - 735. 被引量:1
  • 9Omur O, Akgun A, Ozcan Z, et al. Clinical implications of diffuse hepatic uptake observed in postablativc and post-therapeutic I-131 scan[J]. Clin Nucl Med, 2009, 34(1): 11-14. 被引量:1
  • 10Akta A, Kayak K, Kocaba B, et al. The biodiatribution of radioiodine on posttherapy iodine-131 scans in thyroid cancer patients with chronic renal failure [ J ]. Nucl Med Commun, 2008, 29 ( 11 ) : 943 - 948. 被引量:1

共引文献5

同被引文献133

引证文献17

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部